The Portugal Food and Economic Safety Authority (ASAE) has seized nearly 7,000 cannabis-infused supplements and food products in a sweeping nationwide operation, underscoring a crackdown on a shadowy market that blends legal ambiguity with public health risk. The enforcement push, dubbed "Operation Euphoria," targeted 53 retailers and online platforms in late April and early May 2026, netting everything from gummy bears and chocolates to herbal teas—all laced with Cannabis sativa extracts that Portuguese law does not permit in edibles.
Why This Matters
• Criminal charges filed: 19 criminal cases launched for adulterated food and drug trafficking; 8 administrative penalties for misleading labeling.
• What was seized: Seeds, flowers, resin, pollen (psychoactive materials), plus consumer goods—gummies, lollipops, chocolate bars, pasta, infusions—containing unauthorized cannabinoid extracts.
• Where it happened: Health stores, parapharmacies, pharmacies, supermarkets, and e-commerce sites across Portugal.
• Legal status: Selling CBD or other cannabinoid-based supplements remains illegal in Portugal; they are classified as "novel foods" without safety authorization.
The Legal Blind Spot Behind the Bust
Portugal's regulatory stance on cannabis is a patchwork. While the country decriminalized personal possession in 2001 and legalized medical cannabis in 2018 under strict prescription rules, the sale of cannabidiol (CBD) in dietary supplements and food products remains explicitly banned. Under European Union novel food regulations, any ingredient without a documented history of consumption in Europe before 1997 requires formal safety approval—a hurdle CBD has not cleared for edible use.
Yet walk into many ervanárias (herbal shops), parapharmacies, or browse online, and you will find CBD gummies, chocolate, and infusions marketed with wellness claims. This disconnect between regulatory theory and street-level reality is what ASAE set out to address with Operation Euphoria.
The Portugal pharmaceutical regulator INFARMED restricts cannabis-derived substances to medicines with official market authorization. The same logic extends to food: if it is not approved as medicine, and not approved as food, it cannot be sold—period.
What Inspectors Found in Shops and Warehouses
ASAE inspectors fanned out to 53 businesses, examining stock in brick-and-mortar locations and scrutinizing online catalogs. The haul included 6,822 items, many of which were flower buds, resin, and pollen—materials that carry psychoactive properties due to tetrahydrocannabinol (THC) content. Portuguese law sets a maximum THC threshold of 0.3% for industrial hemp products (raised from 0.2% in March 2023 via Portaria 64/2023), but the seized items often exceeded this limit or were being sold as consumables without any lab certification.
Among the confiscated products were everyday snacks: CBD-infused gummies, lollipops, chocolate bars, pastas, and herbal teas. None bore the requisite Autorização de Colocação no Mercado (ACM) from INFARMED, and many featured labeling that either omitted cannabinoid concentration or made unsubstantiated health claims—practices that violate both food safety law and consumer protection statutes.
The Director-General for Food and Veterinary (DGAV) and ASAE have repeatedly warned that cannabinoid extracts in food are not authorized in Portugal. Yet demand persists, fed by a global wellness trend that portrays CBD as a cure-all for anxiety, inflammation, and insomnia—claims that remain unproven and unapproved in the EU.
Criminal and Administrative Fallout
The immediate legal consequences were swift. ASAE opened 19 criminal cases alleging adulterated food products (género alimentício anormal falsificado por adição) and drug trafficking. Portuguese penal code treats the sale of psychoactive substances outside licensed medical channels as trafficking, even when packaged as chocolate or tea.
An additional 8 administrative violation proceedings were initiated for misleading commercial practices and labeling violations. These cases typically result in fines that can reach tens of thousands of euros for repeat or egregious offenders, and businesses risk having their licenses suspended or revoked.
For context, this is not ASAE's first rodeo. In January 2026, the authority conducted a smaller operation in Porto, Braga, Aveiro, and Guimarães, seizing 3,588 items and opening six criminal cases. The pattern is clear: enforcement is escalating, and the tolerance for gray-market CBD commerce is shrinking.
Impact on Residents and Consumers
For anyone living in Portugal who buys or sells wellness products, the message is unambiguous: CBD edibles are not legal, no matter how many shops stock them or how benign they appear. Consumers who purchase these items online or in stores face no criminal liability—personal possession of small amounts of cannabis remains decriminalized—but they are exposing themselves to unregulated, untested products that may contain harmful contaminants (pesticides, heavy metals) or unsafe concentrations of cannabinoids.
Retailers, on the other hand, are courting serious legal risk. A conviction for trafficking or selling adulterated food can result in prison sentences, steep fines, and the destruction of inventory. Even smaller infractions—like selling a CBD oil with misleading labels—can trigger administrative fines and reputational damage.
For the broader wellness and natural products sector, the crackdown creates uncertainty. Many small business owners believed they were operating in a legal gray zone, selling hemp-derived CBD that met EU agricultural standards. The reality, as ASAE and INFARMED now make clear, is that agricultural legality does not confer food legality. A hemp plant with 0.3% THC may be legally cultivated, but its extracts cannot be legally sold in gummy form.
The Public Health and Economic Equation
Illicit cannabis supplement sales pose a dual threat. On the health front, unregulated products lack the Good Manufacturing Practice (GMP) standards mandatory for licensed pharmaceuticals. Without lab testing, consumers cannot verify cannabinoid content or screen for contaminants. This is particularly concerning given that cannabis use rates in Portugal rose from 7.8% in 2001 to 12.8% in 2022, and overdose rates in Lisbon have doubled since 2019.
Economically, the black and gray markets drain tax revenue and create unfair competition for legitimate businesses. The illicit cannabis market in Europe is valued at over €12 billion, with profits funneled to organized crime. In August 2025, "Operation Erva Daninha" dismantled a network that exploited Portugal's medical cannabis framework to illegally export large quantities of product, exposing vulnerabilities in oversight and eroding confidence in the regulated sector.
Legal operators—those investing in licenses, lab analysis, and compliance—cannot compete with unlicensed vendors selling unverified CBD chocolates at a markup. The result is a distorted market that penalizes compliance and rewards risk-taking.
What Comes Next
ASAE has signaled that enforcement will continue. The authority is coordinating with the Portugal Royal Police (PSP), the Judiciary Police (PJ), and customs officials to monitor imports and e-commerce platforms. Online marketplaces are a particular focus, as cross-border sales complicate jurisdiction and enforcement.
For consumers, the safest route is to avoid CBD edibles and supplements unless prescribed by a physician and dispensed by a licensed pharmacy under the medical cannabis program. Topical CBD products (creams, balms) and aromatic oils remain in a less scrutinized category, but even these should be purchased from reputable suppliers who provide third-party lab certificates.
Retailers should conduct immediate inventory audits, removing any product containing cannabis extracts not explicitly authorized by INFARMED. Labeling must be rigorously accurate, with no health claims beyond those permitted under EU law. Consulting a lawyer familiar with Portuguese food and pharmaceutical regulation is advisable before restocking or launching new product lines.
Portugal's cannabis policy is evolving, but for now, the line is clear: medical cannabis is tightly controlled, industrial hemp is regulated, and CBD edibles are off the table. Operation Euphoria is a reminder that regulatory ambiguity is not a license to sell—and that ASAE is watching.
